ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyZurichLinkster Therapeutics AG
Linkster Therapeutics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Linkster Therapeutics AG develops targeted therapeutics and drug candidates for diseases with unmet treatment needs. The biotechnology company uses its Flycode® technology and antibody platform to engineer antibody candidates and assess their properties and tissue-specific delivery.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Linkster Therapeutics AG

✓ Offered5
Flycode® Technology
Peptide-barcoded antibody screening for in vitro, in vivo and in silico analyses, multiplex screening of large candidate pools, pharmacological profiling and targeted antibody development.
Sybody® Platform
Platform for conformation-specific single-domain antibodies, including library design, selection against difficult targets, rapid discovery within three weeks and research tools for diagnostics and structural biology.
Antibody development and discovery
Translational antibody engineering, identification and optimization of antibodies for specific targets, targeting properties and improved pharmacological profiles.
Partnerships for drug development
Collaborations with pharma and biotech companies to develop or further develop drug candidates, in particular for membrane-bound targets, GPCRs, SLC transporters and kinases.
Development of Targeted Therapeutics
Development of targeted therapeutics and precision medicines with tissue-specific delivery, improved efficacy and reduced off-target effects.
Trust & reputation

ranQ Trust Score of Linkster Therapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Linkster Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Linkster Therapeutics AG scores 74.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Linkster Therapeutics AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Linkster Therapeutics AG scores 22.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.22.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Linkster Therapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Linkster Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Linkster Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Linkster Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Linkster Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Stampfenbachstrasse 142
8006 Zurich
Opening hours
Mon
08:00 - 18:00
Tue
08:00 - 18:00
Wed
08:00 - 18:00
Thu
08:00 - 18:00
Fri
08:00 - 18:00
Sat
08:00 - 18:00
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-343.085.638
Founded
2019 · 7 years
Last commercial register change
June 23, 2025
Employees
1 to 10

Active in 1 of 26 cantons

  • ZHZurich
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    MA
    Mabylon AG
    Schlieren
    NA
    Neurimmune AG
    Schlieren
    NT
    NovaGo Therapeutics AG
    Schlieren
    PA
    Philochem AG
    Otelfingen
    PA
    PureDEL AG
    Zürich Eth-Hönggerberg
    AB
    Araris Biotech AG
    Au Zh
    CR
    Charles River Laboratories Switzerland AG
    Hettlingen
    AA
    Athebio AG
    Schlieren